The latest weapon against inoperable liver cancer is so tiny that it takes millions of them per treatment, but according to interventional radiologists, those microscopic spheres really pack a ...

May 3, 2009 (Copenhagen, Denmark) — A phase 2 study of radioembolization with yttrium-90 has shown it to be effective and safe for the treatment of advanced hepatocellular carcinoma (HCC), with or ...

Peritoneal carcinomatosis from colorectal cancer: Not a lost cause. Background: Y-90 radioembolization has shown promise in the treatment of unresectable metastatic colorectal cancer (mCRC) and ...

Hackensack Meridian Health Riverview Medical Center is pleased to announce that it now offers Y-90 radioembolization, an innovative and minimally invasive method to treat liver tumors without surgery.

This was a prospective single-centre, phase I study to document the maximum tolerated dose (MTD), dose-limiting toxicity (DLT), and the recommended phase II dose for future study of capecitabine in ...

Phase II trial of sorafenib (S) and capecitabine (C) for hepatocellular carcinoma (HCC) in cirrhotic patients (pts). Phase II randomized study comparing concurrent chemoradiation versus neoadjuvant ...

A minimally invasive treatment that delivers cancer-killing radiation directly to tumors shows promise in treating breast cancer that has spread to the liver when no other treatment options remain.

Hackensack Meridian Health Bayshore Medical Center now offers Y-90 radioembolization, an advanced and minimally invasive method to treat liver tumors without surgery. This procedure is used to treat ...

INDIANAPOLIS -- The latest weapon against inoperable liver cancer is so tiny that it takes millions of them per treatment, but according to interventional radiologists at the Indiana University School ...

Largest study of its kind shows minimally invasive treatment may slow disease progression in liver while maintaining quality of life SAN DIEGO (March 24, 2014)—A minimally invasive treatment that ...